Fortrea's New Leadership Appointment
Fortrea, a leading global contract research organization (CRO), has announced a significant change in its leadership with the appointment of Agnieszka (Aggie) M. Gallagher as the new general counsel. Gallagher will be instrumental in shaping the Company's legal strategy and overseeing its operations.
Agnieszka Gallagher's Vision for Fortrea
CEO Anshul Thakral praised Gallagher's extensive executive experience, particularly within the life sciences sector, emphasizing her ability to navigate complex challenges in global companies. Gallagher’s track record includes not only her legal expertise but also her success in aligning legal frameworks with corporate goals. Thakral expressed eagerness about Gallagher's contributions as Fortrea continues to grow and innovate.
Gallagher's Impressive Background
With over 25 years of experience in the life sciences, Gallagher has held significant positions in companies such as Standard Biotools, Inc., where she was the chief legal officer. Her previous roles include serving as general counsel and chief compliance officer at Orasure Technologies, along with leadership positions at Alnylam Pharmaceuticals, ViiV Healthcare, and Pfizer. Gallagher's background provides her with a vast reservoir of knowledge and expertise in managing legal and compliance matters.
Ga Gallagher’s Commitment to Excellence
Gallagher expressed her enthusiasm about joining Fortrea at such a crucial time in the organization's journey, indicating her readiness to collaborate with the global team and partners. Her commitment to upholding high standards of governance and compliance highlights her proactive approach to her new role.
The Role of Fortrea in Healthcare Innovation
Fortrea plays a vital role in the healthcare industry by partnering with both emerging and established biopharmaceutical, biotechnology, and medical device companies. Their focus is on driving innovation that accelerates the delivery of life-changing therapies to patients. Through its solutions in clinical trial management and consulting services, Fortrea leverages three decades of experience in over 20 therapeutic areas.
Understanding Fortrea's Services
As a global leader in clinical development solutions, Fortrea is dedicated to pushing boundaries in the life sciences sector. Their talented and diverse team operates in approximately 100 countries, offering clients agile solutions tailored to their specific needs. With a robust investigator site network and an unwavering commitment to scientific rigor, Fortrea is becoming a transformative force in the industry.
Fortrea Contacts for More Information
For inquiries, Fortrea can be reached through the following contacts:
Tracy Krumme (Investors) - 984-385-6707, Tracy.Krumme@fortrea.com
Sue Zaranek (Media) - 919-943-5422, media@fortrea.com
Kate Dillon (Media) - 646-818-9115, kdillon@prosek.com
Frequently Asked Questions
Who is the new General Counsel of Fortrea?
Agnieszka (Aggie) M. Gallagher has been appointed as the new General Counsel of Fortrea.
What are Gallagher's qualifications?
Gallagher brings over 25 years of experience in the life sciences sector and has held various leadership roles in several prominent companies.
What is Fortrea's core business?
Fortrea specializes in clinical development solutions, offering services to biopharmaceutical, biotechnology, and medical device companies to facilitate healthcare innovation.
How does Fortrea support healthcare innovation?
Fortrea partners with healthcare companies to drive the development of therapies, providing expertise in clinical trial management across multiple therapeutic areas.
Where can I find more information about Fortrea?
For more information, you can visit Fortrea's website at Fortrea.com.
